PPARG and cancer: Previous studies collectively suggest that the peroxisome proliferator-activated receptor gamma (PPARG) interacts with the PTEN-PI3K/AKT signaling pathway, playing a crucial role in regulating chemosensitivity in various cancers, including HSCC [5–8].